Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

被引：1
|
作者：
Bailey, Neil
Tsomo, Tenzin
Szeto, Jennie
Bensinger, William I.
Egan, Daniel
Hegerova, Livia
Mawad, Raya
Batchelder, Ami
Fesler, Joanna
Holdread, Heather
Glennie, Sonia
Hall, Judson
Ferry, Joey
Bailey, Megumi
Kane, David
Pagel, John M.
Patel, Krish
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141074
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Initial Safety Results from a Phase II Study of Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Bailey, Neil
    Tsomo, Tenzin
    Braun, Tori
    Szeto, Jennie
    Bensinger, William I.
    Egan, Daniel
    Mawad, Raya
    Hegerova, Livia
    Funk, Gayle
    Fesler, Joanna
    Glennie, Sonia
    Hall, Judson
    Dunleavy, Vanessa
    Hohmann, Heidi
    Briggs, Jordan
    Mark, Joshua
    Bailey, Megumi
    Pagel, John M.
    Patel, Krish
    BLOOD, 2021, 138
  • [2] Initial Efficacy and Safety of Acalabrutinib Plus RICE in Transplant Eligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Bailey, Neil
    Braun, Tori
    Bailey, Megumi
    Tsomo, Tenzin
    Szeto, Jennie
    Kruidenier, Sandra Benitez
    Dunleavy, Vanessa
    Fesler, Joanna
    Funk, Gayle
    Glennie, Sonia
    Hall, Judson
    Parker, Julia
    Egan, Daniel
    Mawad, Raya
    Dean, Carol A.
    Sullivan, Suzan
    Lu, Chia
    Hohmann, Heidi
    Briggs, Jordan
    Patel, Krish
    BLOOD, 2022, 140 : 3765 - 3766
  • [3] Phase 1/2 Trial of Acalabrutinib Plus Pembrolizumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 9 - 10
  • [4] Acalabrutinib monotherapy in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
    Dyer, Martin J. S.
    De Vos, Sven
    Ruan, Jia
    Flowers, Christopher
    Maddocks, Kami J.
    Rule, Simon
    Hamdy, Ahmed M.
    Izumi, Raquel
    Slatter, J. Greg
    Cheung, Jean
    Frigualt, Melanie M.
    Wei, Helen
    Mourya, Sanchita
    Hunder, Naomi N. H.
    Fowler, Nathan Hale
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] A Phase 1 Study of the Combination of Acalabrutinib and AZD9150 in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Roschewski, Mark
    Munugalavadla, Veerendra
    Nuttall, Barrett
    Burke, Kathleen
    Acar, Melih
    White, Rafael
    Udriste, Maria
    Sharma, Shringi
    Dougherty, Brian
    Flinn, Ian
    Saba, Nakhle S.
    Reagan, Patrick M.
    de Vos, Sven
    Arkenau, Hendrik-Tobias
    Collins, Graham P.
    Mortlock, Andrew
    Patel, Manish R.
    BLOOD, 2021, 138
  • [6] Phase 1/2 trial of acalabrutinib plus pembrolizumab (Pem) in relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL).
    Witzig, Thomas E.
    Maddocks, Kami J.
    De Vos, Sven
    Lyons, Roger M.
    Edenfield, William Jeffery
    Sharman, Jeff Porter
    Vose, Julie
    Yimer, Habte Aragaw
    Wei, Helen
    Chan, Edward M.
    Patel, Priti
    Di Simone, Christopher
    Gandhi, Mitul
    Vaughn, Jennifer
    Kolibaba, Kathryn
    Cheson, Bruce D.
    Samaniego, Felipe
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Prolonged Cytopenias in Autologous Stem Cell Transplantation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Santapuram, Pranav
    Rupji, Manali
    Graiser, Michael
    Waller, Edmund
    Blum, Kristie
    Allen, Pamela
    Koff, Jean
    Heffner, Leonard
    Lechowicz, Mary
    Lonial, Sagar
    Kaufman, Jonathan
    Dhopadkar, Madhav
    Nooka, Ajay
    Blum, William
    Klisovic, Rebecca
    Joseph, Nisha
    Gupta, Vikas
    Langston, Amelia
    Cohen, Jonathan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S396 - S397
  • [8] Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma
    Kato, Koji
    Sugio, Takeshi
    Ikeda, Takashi
    Yoshitsugu, Kanako
    Miyazaki, Kana
    Suzumiya, Junji
    Yamamoto, Go
    Kim, Sung-Won
    Ikegame, Kazuhiro
    Uehara, Yasufumi
    Mori, Yasuo
    Ishikawa, Jun
    Hiramoto, Nobuhiro
    Eto, Tetsuya
    Nakazawa, Hideyuki
    Kobayashi, Hikaru
    Serizawa, Kentaro
    Onizuka, Makoto
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Suzuki, Ritsuro
    BONE MARROW TRANSPLANTATION, 2024, 59 (03) : 306 - 314
  • [9] Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma
    Koji Kato
    Takeshi Sugio
    Takashi Ikeda
    Kanako Yoshitsugu
    Kana Miyazaki
    Junji Suzumiya
    Go Yamamoto
    Sung-Won Kim
    Kazuhiro Ikegame
    Yasufumi Uehara
    Yasuo Mori
    Jun Ishikawa
    Nobuhiro Hiramoto
    Tetsuya Eto
    Hideyuki Nakazawa
    Hikaru Kobayashi
    Kentaro Serizawa
    Makoto Onizuka
    Takahiro Fukuda
    Yoshiko Atsuta
    Ritsuro Suzuki
    Bone Marrow Transplantation, 2024, 59 : 306 - 314
  • [10] Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma
    Kondo, Eisei
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2016, 56 (02) : 100 - 108
12345